… Candida … Candida species are not completely understood, but some medical conditions
may consistently impact the risk of developing candidemia due to non-albicans Candida species…

… of some rare species such as C. kefyr … Candida species distribution, in vitro antifungal
susceptibility together with risk factors, antifungal therapy and outcome of patients with candidemia …

… Candida albicans was the most common species isolated (33.8 %; n = 68), whereas non-albicans
Candida species … The species distribution and outcome of candidemia showed a …

… Patient outcomes 30 days stratified by Candida species and type of units are reported in …
days from the onset of candidemia. C. parapsilosis candidemia was associated with the lowest …

… Candida albicans was the most frequent cause of candidemia at a large tertiary hospital in
China, but antifungal resistance is a growing concern among non-albicans Candida species. …

… Therefore, this retrospective study was undertaken to evaluate the epidemiology, clinical
and microbiologic characteristics, outcomes, and prognostic factors of candidemia in adult …

… We defined candidemia as the isolation of Candida species from at least … candidemia,
including Candida species identification, antifungal resistance determination and patient outcome …

… species distribution vary from different regions. The goals of this study were to report the
current epidemiology of Candida … the impact of appropriate antifungal therapy on the outcome. …

… We retrieved data including clinical characteristics, Candida species distribution, and
antifungal management from electronic health records to identify risk factors for mortality at 28 and …

… Very little is known about the epidemiology of candidemia in … presentation and outcomes of
Candida bloodstream infections … of our Candida species were non-Candida albicans species, …